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Bones hold the key to DNA virus 
history and epidemiology
M. Toppinen1,*, M. F. Perdomo1,*, J. U. Palo2, P. Simmonds3, S. J. Lycett3, M. Söderlund-
Venermo1, A. Sajantila2 & K. Hedman1,4
DNA in human skeletal remains represents an important historical source of host genomic 
information and potentially of infecting viruses. However, little is known about viral persistence 
in bone. We searched ca. 70-year-old long bones of putative Finnish casualties from World War II 
for parvovirus B19 (B19V) DNA, and found a remarkable prevalence of 45%. The viral sequences 
were exclusively of genotypes 2 (n = 41), which disappeared from circulation in 1970´s, or genotype 
3 (n = 2), which has never been reported in Northern Europe. Based on mitochondrial and 
Y-chromosome profiling, the two individuals carrying B19V genotype 3 were likely from the Soviet 
Red Army. The most recent common ancestor for all genotypes was estimated at early 1800s. This 
work demonstrates the forms of B19V that circulated in the first half of the 20th century and provides 
the first evidence of the suitability of bone for exploration of DNA viruses.
The advent of new genomic and sequencing technologies has uncovered in recent years a myriad of 
viral sequences that were previously unknown to coexist with humans. Understanding viral evolutionary 
dynamics may be crucial for better monitoring and predicting the epidemiological trajectory of clinically 
relevant viruses. Thus, tracing the footprints of viruses in human remains may reveal important clues on 
their distribution, adaptation and on the influence that they may have on us.
DNA is most likely to be preserved across time in bone yet little is known about viral persistence in 
this organ. In the present study we searched for viral DNA skeletal remains of putative Finnish soldiers 
that went missing in action during the Second World War (WWII) and whose bodies had been decaying 
in the boreal forest in current Russian territory ever since. The remains have over the past 17 years been 
searched for and repatriated upon discovery to Finland for DNA-based identification1.
As a proof of principle, we examined these bones for human parvovirus B19 (B19V), a highly preva-
lent DNA virus establishing lifelong tissue persistence. B19V DNA has been detected in a range of tissues 
and organs2–12 but as of yet there is no direct evidence of its persistence in bone. The virus, however, 
replicates in erythroid progenitor cells in the bone marrow13–15 and also has been found in mesenchymal 
stromal cells, which can differentiate into cartilage and bone16.
B19V has three genotypes that are differently distributed around the globe. Of these, the most exten-
sively studied and the one responsible for most current clinical cases is genotype 1. In Northern Europe, 
both genotypes 1 and 2 have been encountered in soft tissues of elderly individuals7,8,17; yet a clear 
perspective on the endemic prevalence of each type across the years is lacking, as the time of primary 
infection is not known.
The present work not only explores the suitability of bone for search of viral DNA but also reveals 
unambiguously the forms of B19V that circulated in the first half of the 20th century.
Results
B19V DNA in bone. The B19V genomic prevalence was determined in DNA extracts of long bones 
of 106 anonymous World War II casualties. For this purpose, two quantitative PCRs (qPCR), Pan-B19V 
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qPCR and VP-qPCR, targeting distinct conserved areas of the viral genome (non-structural [NS] and 
viral protein [VP] respectively), were used.
B19V DNA was detected in 48 samples (45%), of which 43 were positive by both qPCRs and five by 
the VP-qPCR only. Viral loads calculated by the Pan-B19V qPCR ranged from 3.7 × 10−1 to 4.1 × 105 
copies/1 μ g of total DNA (mean 2.7 × 104) and by the VP-qPCR from 2.2 × 10−1 to 1.4 × 105 copies/1 μ g 
of total DNA (mean 1.9 × 104) (Fig. 1). The viral loads of the five samples positive solely by the VP-qPCR 
ranged from 2.7 × 100 to 1.7 × 103/1 μ g of total DNA, thus the difference was not due to copy number 
or a lack of Pan-B19V qPCR sensitivity. The product of the VP-qPCR is shorter (121 bp vs 154 bp) and 
may therefore amplify more effectively the possibly fragmented DNA sequences in these bone samples.
All B19V qPCR products were sequenced. Among the samples positive with both qPCRs (n = 43), 
41 showed 96.4%–99.6% total nucleotide identity to the B19V genotype 2 reference sequence (GenBank 
accession number AJ717293), while the remaining two samples (#12 and #38) showed 98.0% and 97.8% 
identity to genotype 3 (GenBank accession number AY083234). The five samples positive with only 
VP-qPCR showed 93.7–99.2% identity to genotype 2 (AJ717293).
No sequences of genotype 1, the currently circulating virus, were detected.
B19 Evolutionary history. Sequences of B19V amplified using Pan-B19V and VP-qPCRs (positions 
1850–2001 and 2709–2835 [numbered using the prototype PVBPRO/M24682 sequences]) were concat-
enated, and analysed together with other publically available, dated sequences of B19V genotypes 1–3. 
Phylogenetic analyses using a best fit maximum likelihood model showed that almost all sequences 
derived from the WWII study group adopted deeper positions in the tree compared to those obtained 
from more recent sampling (Fig. 2; sampling at the time of acute infection or estimated infection times 
shown in sequence labels). Plotting the genetic diversity from the putative ancestral root sequence to the 
observed sequences indicates time-related sequence change in B19V over the observation period (Fig. 3). 
The relatively deep branching of sequences in the genotype-2 clade is consistent with the early infection 
dates in the study subjects (Fig. 2).
Next, overall substitution rates and dates of origin for B19V variants were estimated using BEAST 
under a variety of substitution models, clock rate models and effective population size tree priors. All 
models gave similar results (See Fig. 4, and Supplementary Fig. S1 online), and the estimate from the best 
fit model was 2.11 × 10−4 substitutions/site/year with 95% Highest Posterior Density (HPD) intervals 
(1.18–3.16 × 10−4). The time to most recent common ancestor of all three genotypes was estimated as 
1833 (95% HPD interval: 1751–1893) for the best fit model; and the TMRCA for genotypes 2 and 3 were 
1868 (HPD: 1823–1902) and 1917 (HPD: 1893–1929), respectively (Table 1).
Human DNA profiling. B19V genotype 3 has never before been encountered in Northern Europe. 
Thus, in order to gain insight into the geographical origin of the two individuals that were positive 
for this genotype, the mitochondrial (mt) and Y-chromosomal haplotypes were determined. For both 
samples, 631 bp hypervariable region profiles (HVR-1 and -2) were obtained. Likewise, full 23-locus 
Y-chromosome short tandem repeats profiles (Y-STR) were obtained for the sample 12, but for the sam-
ple 38 the loci DYS533, DYS643 and YGATAH4 could not be reliably typed. No matching mtDNA 
Figure 1. Correlation of B19V DNA copy numbers determined by Pan-B19V and VP qPCRs. Genomic 
B19V DNA was quantified by means of two in-house quantitative PCRs targeting distinct conserved regions 
of the viral genome (NS and VP). Represented are in the y-axis the genomic copies/1 μ g of total DNA of 
individual samples as determined by the Pan-B19V qPCR. In the x-axis, genomic copies/1 μ g of total DNA 
of individual samples as determined by VP-qPCR. In squares are represented the copy numbers of the five 
samples that were positive by the VP-qPCR only.
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Figure 2. B19V phylogenetic tree. Maximum likelihood tree of the combined NS/VP region constructed 
using optimal substitution models (Kimura 2-parameter + invariant sites). Sample dates (acute infection; 
plasma) or predicted infection dates (assumed at 9 years of age; tissue) are shown on labels. Bootstrap re-
sampling was used to determine robustness of groupings; values of 70% or greater shown.
Figure 3. Genetic diversity over time. The genetic distance from the putative ancestral root from the 
maximum likelihood tree (Fig. 2) for each sample is plotted with the corresponding sampling date (circles). 
Dotted line: line of best fit for these points corresponding to a simple substitution rate estimate of 1 × 10–4 
substitutions/site/year. Solid line (mean) and shaded region (95% HPD): overall substitution rate estimate 




Sequences Date Range Date of MRCA*
All 78 1917–2013 1833 (1751–1893)
Type 1 13 1973–2013 1963 (1945–1972)
Type 2 55 1917–2009 1868 (1823–1902)
Type 3 10 1929–1999 1917 (1893–1929)
Table 1.  Dates of most recent common ancestors of B19V genotypes. MRCA, most recent common 
ancestor *Mean value and highest posterior density interval
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or Y haplotypes were found in the forensic in-house database consisting of 200 mtDNA and 893 
Y-chromosomal Finnish haplotypes.
Sample 12 carried the mtDNA haplogroup H, with subhaplogroups H1e and H10a equally supported 
by HaploGrep18,19. The most probable Y-haplogroup for this sample is J1. Based on 9-locus “minimal 
haplotype”, the YHRD database20 suggested South-East European metapopulation as the most likely ori-
gin for this Y chromosome. There were 27 matching minimal haplotypes in the database distributed in 
all continents, but none in Northern Europe.
Sample 38 carried mtDNA haplogroup A, most likely subhaplogroup A12. The Y-chromosome most 
likely belongs to haplogroup N, and based on the Y-STR haplotype the YHRD database suggested Altaic 
origin. Only two matching minimal haplotypes were found in the database, one in the Yakut population 
in Siberia (Sakha Republic, NE Russia), and the other in Vilnius, Lithuania.
Of note, 20/41 B19V genotype 2 positive individuals were identified as Finnish, based on mtDNA 
comparison with living family members and detailed circumstantial information.
Discussion
In the present study we provide evidence that viral nucleic acids can be detected in and genetically char-
acterized from human bone. We found B19V DNA in 45% of long bones from casualties of the Second 
World War. Despite their long exposure (ca. 70 years) to varying environmental conditions in boreal 
wilderness1, the detection frequency was similar to that in modern soft-tissue biopsies2–12, demonstrat-
ing both good preservation of viral nucleic acids in human skeletal remains and high rate of viral DNA 
persistence in vivo. While the B19V genome persists in several tissue types its presence in bone has pre-
viously been only indirectly implied by Cantey et al.21 who reported radiological lucencies in a neonate 
with documented congenital B19V infection.
We found the viral sequences to be exclusively of genotypes 2 and 3. Our data with Finnish soldiers 
support the hypothesis22 that genotype-1 virus, the prototype and vastly predominant form in circulation 
throughout the world, emerged after WWII. Indeed, the present study for the first time sheds light on 
the epidemiological occurrence of B19V between 1923 and 1944, which correspond respectively to the 
median years of birth and death of the identified soldiers.
In order to calculate the rate of B19V sequence change, we used an assumption of primary infec-
tion at the age of 9 and no sequence change after infection as previously specified (Model A22). We 
obtained 2.1–2.2 × 10−4 substitutions/site/year (HPD interval 1.1–3.2 × 10−4) for the combined NS/VP 
region. This was lower than previous estimates based on the whole VP1 gene22 (3.6 × 10−4; HPD inter-
val 2.5–4.6 × 10−4) although this latter estimate was based on a genome region showing substantially 
greater variability than the conserved NS and VP regions targeted in the current study for amplification. 
This nucleotide substitution rate is similar to that of other parvoviruses (e.g. porcine parvovirus (PPV) 
and canine parvovirus (CPV)) which have substitution rates approaching those of RNA viruses (10−4 
substitution/site/year)22–26, despite using the cellular DNA polymerase for their replication. This favours 
Figure 4. Time to most recent common ancestors of B19V genotypes. Estimated time to most recent 
common ancestor of genotypes 1 (pink), 2 (blue) and 3 (orange), as well as that of the whole tree (grey) 
using several models with BEAST. Models 1–3, and 7–9 additionally use the HKY nucleotide substitution 
model with site to site rate variation (HKYG4) and models 4–6 and 10–12 use the SRD06 codon partitioned 
substitution model. Models 1–6 also use a constant population coalescent model (‘constPop’), whereas 
models 7–12 use a Skygrid flexible effective population size prior model with 10 bins over 300 years 
(‘skygrid’). The model quoted in the main text is model 4, with the SRD06 substitution model, strict clock 
and constant population size.
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a continuous evolution of important elements, such as the viral capsid, that have a profound role on 
virus-host interactions.
The HPD intervals of the most recent common ancestors (MRCAs) of genotype 2 and all three gen-
otypes indicated that the genotype 2 infections in the study subjects occurred shortly after the original 
diversification of this genotype (~1868).
The detection of B19V genotype 3 in two individuals was surprising, as this type has never been 
reported in Finland and recorded to date in Ghana, Brazil and India27–32. We investigated the possibility 
that these subjects may not be of Finnish origin. Thus, we further studied their mtDNA and Y chromo-
some profiles in an attempt to clarify the geographical origin.
While the mtDNA haplogroup H in sample 12 is the most common in Europe (frequencies up 
to 50%), it also occurs in North Africa and the Middle East. The Y-STR data suggested a South-East 
European origin. The Y-haplogroup was probably J1, which is frequent in the Caucasus region and in 
the Middle East. In Finland this haplogroup is rare33.
For sample 38 the most probable mtDNA haplogroup was A, which is thus far unobserved in Finland 
yet found primarily in East and North Asia and among the indigenous peoples in America. The Y-STR 
data suggested haplogroup N that has a broad North Eurasian distribution. Although subhaplogroup 
N1c1 is very common in Finland, the particular haplotype found showed rather a Siberian (Yakut) than 
Finnish affinity. Thus, the combined mtDNA and Y chromosome data suggested rather Siberian origin 
for this individual.
While the determination of uniparental haplogroups based on mtDNA HVR-1 and -2 sequences or 
Y-STR profiles can rarely demonstrate geographical origins unambiguously, the combined data help to 
exclude Finnish origin for the two B19V genotype 3 positive individuals. It is likely that those remains 
belonged to soldiers of the Soviet Red Army conscripted from a much wider European and Asian range 
than other European combatants.
In the present work, we demonstrated that DNA viruses can be reliably detected and characterized 
in 7-decade-old human skeletal remains. Such material and potentially much older specimens may thus 
be suitable for investigations of epidemiologies and evolutionary histories of a range of other DNA 
viruses that might be similarly preserved. Further investigations are needed to clarify the suitability of 
this approach for RNA viruses, given the lability of RNA. Interestingly, influenza A virus RNA has been 
amplified in a biopsy of the lung of an influenza victim buried in permafrost since 191834. Bones holding 
a clear history of an individual’s infectious encounters, may ultimately provide a much needed historical 
perspective on human viral diseases.
Materials and Methods
Bone samples. The bones had remained in the battlefields of Karelia district, near the border of 
Finland and Russia at the time of WWII. The climate in this region comprises four divergent seasons, 
with sub-zero temperatures and snow-cover during winter and long day lengths (≤ 20 hrs) during sum-
mer. The soil is generally acidic, with regional and micro-scale variations. The remains were initially 
considered Finnish in origin based on visual inspection of vestiges of military uniforms, ID tags or 
personal belongings1 under the coordination of the Association for Cherishing the Memory of the Dead 
of the War. DNA extracts of altogether 106 bone samples from WWII casualties were obtained from the 
Department of Forensic Medicine, University of Helsinki. The skeletal samples were obtained from femur 
(n = 79), humerus (n = 10), tibia (n = 5), radius (n = 4), fibula (n = 3), ulna (n = 2), calcaneus (n = 1), 
clavicula (n = 1) and os temporale (n = 1).
Plasmid. A plasmid containing a near-full length B19V genotype 1 genome served in PCR as positive 
control and was utilized in dilution series as a standard to quantify the amount of B19V DNA in each 
sample.
DNA purification. For each individual, a section of bone of approximately 10 cm was obtained for 
DNA analysis after anthropological investigation of the remains. In order to minimize the external 
DNA contamination and other impurities, bone samples were first cleaned mechanically using a tooth-
brush and distilled water, then shortly immersed in sodium hypochlorite (0.1%), and finally in ethanol 
(96.1 w-%). After these washing steps the bones were allowed to dry for 72 h in RT in a laminar hood.
The outermost surface was removed and bone powder for DNA extraction was obtained with a den-
tist drill (W&H Dentalwerk, Bürmoos, Austria) using sterilized blades. Approximately 1 g of fine bone 
powder was obtained and divided into two aliquots for extraction.
“Total lysis” DNA extraction35 proceeded with incubation of bone powder with 7.5 ml of lysis buffer 
(0.5 M EDTA, 1% N-lauroylsarcosine, pH 8.0) and 2 mg of proteinase K (Promega, USA) overnight at 
+ 56 °C with shaking. The unlysed debris was pelleted by centrifuging the sample for 10 min at 1300 × g 
and the supernatant (c. 7.5 ml) was transferred to Amicon® Ultra-15 30 K tubes (EMD Millipore, USA) 
for concentration to a final volume of 500 μ l. The supernatant was then washed once by adding 2 ml 
of distilled water in the lysate and centrifuging for 1 h at 2500 × g. After this, the extract underwent 
purification with QIAquick® PCR Kit (Qiagen, Germany) according to manufacturer’s instructions to a 
final elution volume of 40 μ l. Negative extraction controls (ddH2O) were run in parallel with the actual 
samples.
www.nature.com/scientificreports/
6Scientific RepoRts | 5:17226 | DOI: 10.1038/srep17226
The amount of total DNA in each sample was measured by NanoDrop 1000 spectrophotometer 
(Thermo Scientific, USA).
B19V quantitative PCRs. The PCR reaction mixes were produced in a clean room dedicated only to 
this purpose and the template was added in a separate room in a laminar hood dedicated to PCR work. 
Negative PCR controls were included in all assays. The laminar hoods were cleaned with Barrycidal 36 
disinfectant (Fisher Scientific, United Kingdom) and 70% EtOH and were treated with UV always before 
use. Filtered tips and single-use disposable materials were utilized in each step. All the amplifications 
were done with the Stratagene Mx3005P (Agilent Technologies, USA) qPCR thermal cycler.
Two B19V qPCRs were used. The Pan-B19V qPCR targeting a 154 bp region of B19V NS1 gene was 
performed as described36.
The other B19V-qPCR was designed to amplify a 121 bp region of the VP gene using a forward primer 
(5′ -CATGCCTTATCAYCCAGTARCAGT-3′ ) and a reverse primer (5′ -AGGCCCAACATAGTTAGTACCG). 
The qPCR reaction consisted of 1 × Maxima SYBR Green Master mix (Thermo Scientific, Lithuania) with 
0.03 μ M of ROX passive reference dye, 0.6 μ M each of the forward and reverse primers, 200 ng or 5 μ l tem-
plate DNA, and nuclease-free water to a final volume of 25 μ l. After an initial denaturation at 95 °C for 
10 min, the qPCR cycles were 95 °C for 15 sec and 58 °C for 1 min, altogether 40 cycles. After the amplifi-
cations, melting curve analysis was performed as follows: denaturation at 95 °C for 1 min, 45 °C for 30 sec, 
0.01 °C/sec ramping from 45 °C to 95 °C, and finally 95 °C for 30 sec. The adaptive fluorescence baseline was 
automatically calculated by the MxPro–Mx3005P v. 4.10 software (Agilent Technologies) and the threshold 
for the quantification cycle (Cq) was set at 10 times the standard deviation of the mean fluorescence baseline 
in cycles 5–9.
The analytical sensitivity of the VP-qPCR assay was determined with serial dilutions of B19V geno-
type 1–3 plasmids at 500, 200, 100, 50, 20, 10 and 5 copies/reaction. After optimization, the VP-qPCR 
amplified and quantified all three B19V genotypes equally, with detection sensitivities of ≤ 10 copies/
reaction of genotype 1–3 plasmid templates.
The analytical sensitivity of the Pan-B19V qPCR was ≤ 10 copies/reaction of genotype 1–3 plasmid 
templates, as previously specified36.
In order to analyse the specificity and functionality of the VP-qPCR, human DNA extracted from 
A549 cells (total of 0.5 μ g) was used as template, by itself or spiked to 1.00E+ 02 copies/μ l of B19V plas-
mids. The qPCR was unaffected by the human A549 DNA.
B19V sequencing and phylogenetic analysis. The products of both qPCRs were purified with 
Diffinity RapidTip2 (Sigma Aldrich, USA) and sequenced with the corresponding qPCR primers at the 
Haartman Institute Sequencing Unit.
Phylogenetic analysis was performed on altogether 78 genotype-1, -2 and -3 sequences (of which 43 
from this study) by constructing maximum likelihood trees using the optimal nucleotide substitution 
model identified in ModelTest (Kimura 2 parameter with invariant sites) as implemented in the MEGA6 
package37. Genetic diversity for each of the sequences from the putative ancestral root sequence was cal-
culated using Path-o-gen v. 1.4 (http://tree.bio.ed.ac.uk/software/pathogen/) and plotted together with a 
simple estimate of the overall substitution rate from the line of best fit (linear regression).
Dated sequences were further analysed using the BEAST package (v.1.8.1)38. In order to estimate 
the overall substitution rate (clock rate) and time to most recent common ancestor (TMRCA) the 
Shapiro-Rambaut-Drummond-2006 (SRD06) substitution model, strict clock model, and constant pop-
ulation size tree priors were used. Selections of other models (Hasegawa, Kishino and Yano [HKY] or 
General Time Reversible [GTR] substitution models; uncorrelated relaxed log normal clock or uncorre-
lated relaxed exponential clock; exponential growth, Bayesian skyline and Bayesian skygrid tree priors) 
were also considered and these produced comparable estimates for the overall substitution rate and 
MRCAs. The TMRCA and clock rate estimates for HKY/SRD06, strict/relaxed clock, constant popula-
tion/skygrid can be found in Fig. 4 and Supplementary Fig. S1 (online). Comparison of these models by 
Bayes Factor (BF) test in TRACER (version 1.6, http://beast.bio.ed.ac.uk/Tracer) using Bayes Factor tests 
(Akaike Information Criteration39) revealed that the SRD06 model was preferred over HKY and GTR 
models (BF > 3), and that the more complex relaxed clock and variable population size models were not 
significantly better than the strict clock and constant population size models. Marginal likelihood esti-
mation by stepping stone sampling and path sampling39, to more accurately distinguish between clock 
models, also confirmed that using the strict clock was most appropriate (difference in Log marginal 
likelihood < 3). Hence final model selections were SRD06, strict clock, constant population size, and the 
final parameter estimates were drawn from the combination of two independent Markov Chain Monte 
Carlo (MCMC) runs consisting of 10 million steps after allowing 1 million steps burn-in (10%) per run.
mtDNA and Y chromosome studies. Mitochondrial hypervariable segments 1 and 2 (positions 
16024–16385 and 72–340) were sequenced as described previously40. The sequencing products were 
resolved using ABI3500XL sequencer and the data analysed using Sequencher v.4.8 software (Gene 
Codes). Based on the sequence data the haplogroup estimation was performed using HaploGrep based 
on Phylotree v. 16 (http://www.haplogrep.uibk.ac.at)18,19. The haplotype frequencies in different parts of 
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the World were searched in the EMPOP database (version 23, release 11) including both the forensic 
and literature databases.
The Y-chromosome 23-locus Y-STR profiles were obtained using the forensic PowerPlex Y23 genotyp-
ing kit (Promega) using 1 μ l (approximately 0.5–1 ng) of the DNA extract as a template. The PCRs were 
performed according to the manufacturer’s recommendations except that the total reaction volume was 
reduced to 12.5 μ l (0.5× the recommended). The products were resolved using ABI3500XL sequencer 
and the data analysed using GeneMapper ID-X (Applied Biosystems, USA).
The Y-chromosomal haplogroups were estimated based on the Y-STR profiles using the web based 
Haplogroup Predictor (Whit Athey; http://www.hprg.com/hapest5/). The geographical origin of the hap-
lotypes was assessed through database searches against the forensic YHRD database (Sascha Willuweit 
& Lutz Roewer, release R48, 10th November 2014; http://yhrd.org).
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